Skip to main content

Published locations for MCL: Ibrutinib could become the ‘new standard’

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. MCL: Ibrutinib could become the ‘new standard’

User login

  • Reset your password
  • /content/mcl-ibrutinib-could-become-new-standard
  • /hematologynews/article/260069/mantle-cell-lymphoma/mcl-ibrutinib-could-become-new-standard
  • /hematology-oncology/article/260069/mantle-cell-lymphoma/mcl-ibrutinib-could-become-new-standard
  • /breast-cancer-icymi/article/260069/mantle-cell-lymphoma/mcl-ibrutinib-could-become-new-standard
  • /b-cell-lymphoma-icymi/article/260069/mantle-cell-lymphoma/mcl-ibrutinib-could-become-new-standard